Biosensors   

Is Biosensors a good buy?

JJ.... is ur call..... since u r Elite... im sure u know what to do..... i cant be tell u right....

anyway...is easy to say here the "enter point" and here the "selling point".... when u have the chart in front of u.... 

too bad.... im a mech guy..... can only be working in engineering side, dont see any opening there...

im not going to time the mkt ......but time in the mkt....... is ur call....bro....

 

biosenser is hiring today !

hmm... marketing manager... 

 

The "new" baloon report mentioned yesterday must have scared off some investors.  That probably pressed BIG share price below 80cts down to 73.5 cts because investors are somehow spooked by the news and shortists took the opportunity to sell.

Now that people know that the Baloon procedures failed some live tests, confidence on BIG should return.  Despite DOW badly beaten on Friday, I believe BIG share price will recover above 80 cents next week with short covering and also those frightened investors who let got on Friday to quickly buy back their shares.

 

when is big going to make a BIG announcement? 2 months from now? from chart i see every spike in price every 3 months. when is the take over? haiz...

 

jackjames Elite	Posted: 08-Mar-2008 09:25
x 0 x 0	novena_33, how? i step backward from 0.79 to 0.69 now... will i get it at 0.69 ? sometimes, if you follow buy at 70 cents region and sell at 85 cents, practise this buy low and sell high, biosensor really make you earn at least 6 times... always in this manner... i think this can really piss off some of the value investor.

 

Each has their own strategy. I wouldn't say yours is a wrong strategy. If it works well for you, then its fine.   

 

To coat a balloon and push it to the clogged artery and then expand the balloon can create fragments on the drug coating leading to clots which is the very thing that should be avoided. This couldn't be that simple a solution that was not thought of even before stenting. Sure, a certain percentage over a year or so would work but in more severe cases (which most coronary problems are) could lead to a higher level of restenosis. Clearly, the goal of this new development is to make a process as cheap as possible (as quickly as well) and to tell patients that they do not need expensive drugs for life (such as Plavix which costs $3-$4 per tablet). How can such a small clinical trial expect to acquire certification in so short a time ?

 

novena_33, how? i step backward from 0.79 to 0.69 now... will i get it at 0.69 ?

sometimes, if you follow buy at 70 cents region and sell at 85 cents, practise this buy low and sell high, biosensor really make you earn at least 6 times... always in this manner... i think this can really piss off some of the value investor.

 

This is my old post a few months back:

Did you guys notice JNJ at TCT2007 didn't present any new breakthrough DES? Thats because they have no new weapon in hand. JNJ is always on the prowl to make acquisitions for medical device technological advancement to remain dominant. Last time when BIG rejected JNJ's offer (which was already more than 100% premium), then JNJ went on and offered Conor. Its really a waste JNJ bought Conor instead of BIG. Conor was a farce (revolutionary innovation but not proven) from the beginning to the end. At that time JNJ offered Conor more money than BIG. This could be due to Conor having their CE and FDA IDE. I think BIG's CEO is disappointed that JNJ "looked down" on BIG's advancement in drug and stent technology by offering a lower price compared to Conor. Everything BIG uses are proprietary and well patented. So what if Conor had CE? Look at Conor's IP and patents. Look at their clinical trials....all total failure. JNJ has to do a total write-off for buying Conor. I only start scooping up BIG shares in large amount after Conor's disaster on 7 May 2007. This is a very big news for BIG and our share price still hardly moved. What the bird!!! I know for sure takeover scenario will be back in action. It is just a matter of price. No $3 no sell (sorry hor that was months ago). If LEADERS trial result is excellent, the price tag will definitely go up. No one has done a RCT head on challenge and show convincingly that their DES is more superior than Cypher. BIG's LEADERS trial will show JNJ Cypher is obsolete. JNJ's Cordis unit now internal management already very messy over Conor's failure and have to deal with newer players. We should give them some time to settle their own problems and finally come up with an offer we cannot refuse. BIG is the very last worthwhile takeover target in the whole DES industry. There are many new "revolutionary" DES players but many will eventually flop like Conor. Revolutionary claims are useless and must be backed by proven clinical trials. BIG has the proven top class clinical results which is the best this DES industry has ever seen. BIG is small, but has the most potential. If JNJ buy up BIG, they will have the lastest DES weapon to fend-off all newer DES like Xience and Endeavor. BIG is what JNJ need to be the most dominant DES player for the next 10 years. Even if JNJ don't want to come up with a good offer price, BIG has the capability to go independent and become a major stent player globally in its own right eventually. The best DES will finally prevail. BIG is clearly on the way to become a global DES powerhouse and BIG's key shareholders will never sell BIG cheap.

***We just saw two "live" failures of another new revolutionary invention. Balloon method was used in the 1970s before BMS in the 1980s. 30 years later coat the old balloon catether with some drug and claim it is better than Biomatrix? Pooi!!! Balloon method is only for less severe clogging and is not a long term solution to widen the clogged vessel. There is simply no scaffold to prop out the clogged vessel internally.

 

 

US is not doing good tonight ... let hope something good next monday

 

hope that poor chap...nothing bad happen...

sure is bad publicity for them...

 

The procedure will involve inserting the tiny balloon capable of delivering an anti-clogging drug into a blocked artery - fail

 

 

bro what u mean failed?

 

Confirm that the "balloon" company failed 2 patient during todays live demo in NUH.Bio hold a conference after 5pm to clarify what is written in today Strait Time..

 

 

About 3 weeks ago, I dumped mine @.83 (with a small loss) ...
Then after I dumped, it went to a high of .91...

But now today, it fell to a low of .70... very difficult to play this counter...  

 

wow.. hit 0.74 already.. hopefully all "small" not ardent big supporters unloaded by then at 80+c.. and "good" news for people who wan to buy it.. cos its cheaper now.. I think i can get cheaper at 64c. i think closing will be 0.735..

not vested. good luck..

Arbitrager Member

Posted: 03-Mar-2008 17:27

x 0 x 0 * Alert Admin

Well like i mentioned eariler.. this stock is actively traded by short-term traders.. no interest from long term BBs. seems like traders are getting sick of this counter.. well fret not.. this counter is still well-liked by retails.. I am sure we have quite a handful of ardent supporters here. good luck for those vested.. more bargain hunting for those who want to hold BIG in the coming days. 29-Feb-2008 10:47 Biosensors   /   Is Biosensors a good buy? Arbitrager Member this counter is died.. how to cheong when no insti interest?? and the news of emloyee share option is no good news at all... its dilutive by nature and its definitely not good news for existing shareholders.. lesser EPS and anyway BIG is not profitable yet.. I dun think it will stay above 80c

 

Anyone want to predict the closing?

 

I am neutral to all these reports. Some say will cheong, some say will drop like stone. But eventually they are all half right and half wrong. I am vested in tranches, the latest was 78¢, overall slight ABOVE water, but I am holding on. I think healthcare industry is a recession proof business. If your love ones needs it (healthcare) during recession, I believe you will not stinge on a cheaper product/service. BIG should turn around to profitability next few quarters, I am buying its future, but I do not like the idea of TAKEOVER which I explain in my past thread. Cheers!

 

yup, like I said that was the DJ newsbite. but I could never find the analyst report, only a posting over at CNA forum. financial journalism must really be going to the dogs. they might as well say BIG is due for a takeover based on postings here in SJ. (which would probably be nearer to the truth)   :)

 

 

Here was the posting, 21 Jan 08.....0304 GMT [Dow Jones] Biosensors (B20.SG) off 4.3% at S$0.995 on strong volume after trade resumption as investors sell on news company has won coveted CE mark for its flagship Biomatrix drug-eluting stent, which allows it to commercialize product in countries that recognize award. Local house institutional dealer says shares not worth chasing given huge run-up to announcement; "Biosensors looks like a one-trick-dog with no other product visibility in the pipeline." Adds stock "outrageously expensive" based on valuations, while earnings outlook bleak as firm not making money, reported US$11 million loss in 2Q. Support at 20-day moving average of around S$0.91. (FKH)